Tampa, FL · Founded 2013 · Privately Held (backing)
Developer of a medical device system designed to combat cognitive impairment caused by neurodegenerative conditions. NeuroEM Therapeutics is based in Tampa, FL and was founded in 2013. It was valued at $17 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $6.2 million across 2 recorded rounds; the latest was a $1.9 million seed round in Apr 2025.
PMV mark · valuation
$17.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$6.2M
Last round
Seed Round
Apr 2025
Cap table — not yet on record
NeuroEM Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NeuroEM Therapeutics with a free account
·Watch NeuroEM Therapeutics: the Monday email on marks, rounds and moves
Where does NeuroEM Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across NeuroEM Therapeutics's 2 recorded funding rounds.
